Revelation Biosciences Inc (REVB) Stock Price, Quote & News

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology

Sector: Healthcare

Phone: (650) 800-3717

Website: www.revbiosciences.com

Address:

4660 La Jolla Village Drive, Suite 100, San Diego, United States

Chickendinner1 Nov. 14 at 8:49 AM

$REVB still no volume. I’m scared it will end up sub .50s then iim gonna need a 200% run to breakeven. What a fkn POS

0 · Reply

_ReddBullyz Nov. 12 at 4:43 PM

Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $REVB $NUWE $LVLU $LRHC Viewz

2 · Reply

revuelto Nov. 11 at 10:29 PM

$REVB looks like this one is ready to tank some more …wait for the year end tax loss selling.…give it time, this will strongly bounce..

1 · Reply

JSP_Dilution_Player Nov. 11 at 4:19 PM

$REVB any good news this is going to pop. They recently collected money in Sept via warrants.

1 · Reply

JSP_Dilution_Player Nov. 10 at 10:01 PM

$REVB without news it hit 1.17 after hrs... with news shorts wont have time to cover

0 · Reply

JSP_Dilution_Player Nov. 10 at 8:46 PM

$REVB give us news and this runs

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:27 PM

$REVB low market cap and big market potential.

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:11 PM

$REVB 5 different program and all have big market potential. drop good PR this can pop 100%

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:07 PM

$REVB They are talking about $19 billion market potential. few programs and all with big market potential. Just one need to hit and market cap wont be wont be under $10 million. current market cap is low vs potential market potential.

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:03 PM

$REVB added today. trading under cash and low burn per qtr. Recently insiders added at 1.28 it is trading at $1.03.

1 · Reply

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

Oct 29, 2025, 9:00 AM EDT - 16 days ago

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

Oct 15, 2025, 5:00 PM EDT - 4 weeks ago

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

Sep 11, 2025, 8:30 AM EDT - 2 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

Sep 10, 2025, 7:20 AM EDT - 2 months ago

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

Sep 9, 2025, 4:55 PM EDT - 2 months ago

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

Sep 9, 2025, 8:00 AM EDT - 2 months ago

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

Aug 8, 2025, 6:30 AM EDT - 3 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

Jul 24, 2025, 9:00 AM EDT - 4 months ago

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Jul 16, 2025, 9:00 AM EDT - 4 months ago

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Jul 1, 2025, 5:26 PM EDT - 4 months ago

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

May 29, 2025, 4:05 PM EDT - 6 months ago

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 6 months ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 23, 2025, 4:05 PM EDT - 6 months ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 8, 2025, 4:15 PM EDT - 6 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Apr 29, 2025, 9:00 AM EDT - 7 months ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Mar 17, 2025, 6:00 AM EDT - 8 months ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 13, 2025, 6:00 AM EDT - 8 months ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 6, 2025, 4:15 PM EST - 9 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Feb 26, 2025, 6:00 AM EST - 9 months ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 24, 2025, 6:00 AM EST - 9 months ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Jan 24, 2025, 6:00 AM EST - 10 months ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 21, 2025, 6:00 AM EST - 10 months ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 13, 2025, 6:00 AM EST - 10 months ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 6, 2025, 6:00 AM EST - 11 months ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Dec 3, 2024, 8:38 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 2, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Nov 12, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 8, 2024, 4:15 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Sep 24, 2024, 6:00 AM EDT - 1 year ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Aug 21, 2024, 5:30 PM EDT - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Jun 24, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 13, 2024, 9:21 AM EDT - 1 year ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

May 10, 2024, 4:52 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Mar 22, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 13, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Mar 4, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Feb 13, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Feb 9, 2024, 8:35 AM EST - 1 year ago

Top 5 Health Care Stocks That Are Preparing To Pump In February

CNSP GILD ZLAB

Feb 5, 2024, 4:41 PM EST - 1 year ago

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Feb 1, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Jan 30, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Jan 23, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

Nov 13, 2023, 4:05 PM EST - 2 years ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Oct 12, 2023, 9:00 AM EDT - 2 years ago

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

Oct 4, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

Oct 2, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

Aug 11, 2023, 4:10 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023

Chickendinner1 Nov. 14 at 8:49 AM

$REVB still no volume. I’m scared it will end up sub .50s then iim gonna need a 200% run to breakeven. What a fkn POS

0 · Reply

_ReddBullyz Nov. 12 at 4:43 PM

Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $REVB $NUWE $LVLU $LRHC Viewz

2 · Reply

revuelto Nov. 11 at 10:29 PM

$REVB looks like this one is ready to tank some more …wait for the year end tax loss selling.…give it time, this will strongly bounce..

1 · Reply

JSP_Dilution_Player Nov. 11 at 4:19 PM

$REVB any good news this is going to pop. They recently collected money in Sept via warrants.

1 · Reply

JSP_Dilution_Player Nov. 10 at 10:01 PM

$REVB without news it hit 1.17 after hrs... with news shorts wont have time to cover

0 · Reply

JSP_Dilution_Player Nov. 10 at 8:46 PM

$REVB give us news and this runs

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:27 PM

$REVB low market cap and big market potential.

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:11 PM

$REVB 5 different program and all have big market potential. drop good PR this can pop 100%

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:07 PM

0 · Reply

JSP_Dilution_Player Nov. 10 at 5:03 PM

$REVB added today. trading under cash and low burn per qtr. Recently insiders added at 1.28 it is trading at $1.03.

1 · Reply

ZacksSCR Nov. 7 at 4:10 PM

$REVB Ready to Advance Groundbreaking Treatment https://buff.ly/SaUKYZ0

1 · Reply

revuelto Nov. 7 at 1:29 PM

$REVB missed the “enhancing shareholder value”…read any nano or micro cap pr…they all say the same thing…“enhancing” usually translates to more dilution 😀

0 · Reply

revuelto Nov. 7 at 1:26 PM

$REVB “believe” and “look forward to” are meaningless and sound desperate…who would even want to fund or partner with them? this is just another lab experiment like in med school unless proven, not saying there won’t be spikes but they’ll be short lived…dilution will show up again for revelation much sooner…

1 · Reply

RealRainmaker Nov. 7 at 11:30 AM

$REVB

0 · Reply

RealRainmaker Nov. 7 at 11:20 AM

$REVB

0 · Reply

d_risk Nov. 7 at 12:05 AM

$REVB - REVELATION BIOSCIENCES, INC. - 10Q - Updated Risk Factors REVB drops FDA delay risks but flags new concerns over AI integration challenges and regulatory uncertainty, plus potential impacts from shifting US and global trade policies. #Biotechnology #TradePolicy #RegulatoryUncertainty #AIIntegration #FDARegulation 🟢 Added 🟠 Removed https://d-risk.ai/REVB/10-Q/2025-11-06

1 · Reply

Greyghost013 Nov. 6 at 10:54 PM

$REVB earnings out. Considerable less loss per share year over year but still down. -1.33 est / act -1.77 per share this quarter.

0 · Reply

RealRainmaker Nov. 6 at 6:22 PM

$REVB bought more just before the drop

0 · Reply

Prof_Amen1 Nov. 6 at 5:23 PM

$REVB so? News?

1 · Reply

Prof_Amen1 Nov. 6 at 5:22 PM

$REVB 0,10$ ....

0 · Reply

revuelto Nov. 6 at 5:16 PM

$REVB hopefully they run it up after it drops another 32% 😀

0 · Reply

mmmsss Nov. 6 at 5:11 PM

$REVB Did not expect this even in my wildest imagination given it was around 2.50 when trial results hit...mgmt truly sucks!!!

0 · Reply

Market Cap	14.05M
Revenue (ttm)	0.00
Net Income (ttm)	-15.04M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	171,700
Avg Vol	495,852
Day's Range	N/A - N/A
Shares Out	15.40M
Stochastic %K	17%
Beta	-0.11
Analysts	Strong Sell
Price Target	$21.25